vs
FMC CORP（FMC）与LifeStance Health Group, Inc.（LFST）财务数据对比。点击上方公司名可切换其他公司
FMC CORP的季度营收约是LifeStance Health Group, Inc.的2.0倍（$759.0M vs $382.2M），LifeStance Health Group, Inc.净利率更高（3.1% vs -37.0%，领先40.1%），LifeStance Health Group, Inc.同比增速更快（17.4% vs -4.0%），LifeStance Health Group, Inc.自由现金流更多（$46.6M vs $-628.1M），过去两年LifeStance Health Group, Inc.的营收复合增速更高（12.8% vs -14.5%）
FMC公司是总部位于美国宾夕法尼亚州费城的化工制造企业，1883年创立之初以生产杀虫剂为主，后续逐步拓展业务至其他领域。二战期间曾为美国陆军部设计生产两栖履带登陆车，目前在全球拥有7000名员工，业务布局广泛。
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
FMC vs LFST — 直观对比
营收规模更大
FMC
是对方的2.0倍
$382.2M
营收增速更快
LFST
高出21.5%
-4.0%
净利率更高
LFST
高出40.1%
-37.0%
自由现金流更多
LFST
多$674.7M
$-628.1M
两年增速更快
LFST
近两年复合增速
-14.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $759.0M | $382.2M |
| 净利润 | $-281.2M | $11.7M |
| 毛利率 | — | — |
| 营业利润率 | -10.6% | 4.7% |
| 净利率 | -37.0% | 3.1% |
| 营收同比 | -4.0% | 17.4% |
| 净利润同比 | — | 264.1% |
| 每股收益（稀释后） | $-2.25 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FMCLFST
| Q1 26 | $759.0M | — | ||
| Q4 25 | $1.1B | $382.2M | ||
| Q3 25 | $542.2M | $363.8M | ||
| Q2 25 | $1.1B | $345.3M | ||
| Q1 25 | $791.4M | $333.0M | ||
| Q4 24 | $1.2B | $325.5M | ||
| Q3 24 | $1.1B | $312.7M | ||
| Q2 24 | $1.0B | $312.3M |
净利润FMCLFST
| Q1 26 | $-281.2M | — | ||
| Q4 25 | $-1.7B | $11.7M | ||
| Q3 25 | $-569.3M | $1.1M | ||
| Q2 25 | $66.7M | $-3.8M | ||
| Q1 25 | $-15.5M | $709.0K | ||
| Q4 24 | $-16.3M | $-7.1M | ||
| Q3 24 | $65.0M | $-6.0M | ||
| Q2 24 | $295.1M | $-23.3M |
毛利率FMCLFST
| Q1 26 | — | — | ||
| Q4 25 | 39.8% | — | ||
| Q3 25 | 23.8% | — | ||
| Q2 25 | 38.7% | — | ||
| Q1 25 | 40.0% | — | ||
| Q4 24 | 42.9% | — | ||
| Q3 24 | 36.3% | — | ||
| Q2 24 | 38.3% | — |
营业利润率FMCLFST
| Q1 26 | -10.6% | — | ||
| Q4 25 | -130.8% | 4.7% | ||
| Q3 25 | -73.1% | 2.0% | ||
| Q2 25 | 12.0% | -0.9% | ||
| Q1 25 | 7.4% | 0.5% | ||
| Q4 24 | 19.2% | 0.3% | ||
| Q3 24 | 12.7% | 0.0% | ||
| Q2 24 | 6.0% | -5.1% |
净利率FMCLFST
| Q1 26 | -37.0% | — | ||
| Q4 25 | -158.8% | 3.1% | ||
| Q3 25 | -105.0% | 0.3% | ||
| Q2 25 | 6.3% | -1.1% | ||
| Q1 25 | -2.0% | 0.2% | ||
| Q4 24 | -1.3% | -2.2% | ||
| Q3 24 | 6.1% | -1.9% | ||
| Q2 24 | 28.4% | -7.5% |
每股收益（稀释后）FMCLFST
| Q1 26 | $-2.25 | — | ||
| Q4 25 | $-13.77 | — | ||
| Q3 25 | $-4.52 | — | ||
| Q2 25 | $0.53 | — | ||
| Q1 25 | $-0.12 | — | ||
| Q4 24 | $-0.13 | — | ||
| Q3 24 | $0.52 | — | ||
| Q2 24 | $2.35 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $390.9M | $248.6M |
| 总债务越低越好 | $2.8B | $282.8M |
| 股东权益账面价值 | $1.8B | $1.5B |
| 总资产 | $9.4B | $2.2B |
| 负债/权益比越低杠杆越低 | 1.50× | 0.19× |
8季度趋势，按日历期对齐
现金及短期投资FMCLFST
| Q1 26 | $390.9M | — | ||
| Q4 25 | $584.5M | $248.6M | ||
| Q3 25 | $497.7M | $203.9M | ||
| Q2 25 | $438.2M | $188.9M | ||
| Q1 25 | $315.3M | $134.3M | ||
| Q4 24 | $357.3M | $154.6M | ||
| Q3 24 | $416.7M | $102.6M | ||
| Q2 24 | $471.5M | $87.0M |
总债务FMCLFST
| Q1 26 | $2.8B | — | ||
| Q4 25 | $3.4B | $282.8M | ||
| Q3 25 | $3.4B | $284.6M | ||
| Q2 25 | $3.4B | $286.4M | ||
| Q1 25 | $3.1B | $288.2M | ||
| Q4 24 | $3.1B | $290.0M | ||
| Q3 24 | $3.1B | $287.3M | ||
| Q2 24 | $3.1B | $288.0M |
股东权益FMCLFST
| Q1 26 | $1.8B | — | ||
| Q4 25 | $2.1B | $1.5B | ||
| Q3 25 | $3.8B | $1.5B | ||
| Q2 25 | $4.4B | $1.5B | ||
| Q1 25 | $4.4B | $1.5B | ||
| Q4 24 | $4.5B | $1.4B | ||
| Q3 24 | $4.6B | $1.4B | ||
| Q2 24 | $4.6B | $1.4B |
总资产FMCLFST
| Q1 26 | $9.4B | — | ||
| Q4 25 | $9.7B | $2.2B | ||
| Q3 25 | $12.1B | $2.1B | ||
| Q2 25 | $12.3B | $2.1B | ||
| Q1 25 | $11.8B | $2.1B | ||
| Q4 24 | $11.7B | $2.1B | ||
| Q3 24 | $12.2B | $2.1B | ||
| Q2 24 | $12.1B | $2.1B |
负债/权益比FMCLFST
| Q1 26 | 1.50× | — | ||
| Q4 25 | 1.62× | 0.19× | ||
| Q3 25 | 0.89× | 0.19× | ||
| Q2 25 | 0.76× | 0.19× | ||
| Q1 25 | 0.71× | 0.20× | ||
| Q4 24 | 0.69× | 0.20× | ||
| Q3 24 | 0.68× | 0.20× | ||
| Q2 24 | 0.68× | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $57.6M |
| 自由现金流经营现金流 - 资本支出 | $-628.1M | $46.6M |
| 自由现金流率自由现金流/营收 | -82.8% | 12.2% |
| 资本支出强度资本支出/营收 | 2.2% | 2.9% |
| 现金转化率经营现金流/净利润 | — | 4.93× |
| 过去12个月自由现金流最近4个季度 | $-154.0M | $110.0M |
8季度趋势，按日历期对齐
经营现金流FMCLFST
| Q1 26 | — | — | ||
| Q4 25 | $657.1M | $57.6M | ||
| Q3 25 | $-184.2M | $27.3M | ||
| Q2 25 | $65.9M | $64.4M | ||
| Q1 25 | $-545.0M | $-3.1M | ||
| Q4 24 | $427.9M | $62.3M | ||
| Q3 24 | $159.5M | $22.7M | ||
| Q2 24 | $292.2M | $44.1M |
自由现金流FMCLFST
| Q1 26 | $-628.1M | — | ||
| Q4 25 | $631.1M | $46.6M | ||
| Q3 25 | $-207.9M | $17.0M | ||
| Q2 25 | $50.9M | $56.6M | ||
| Q1 25 | $-576.6M | $-10.3M | ||
| Q4 24 | $406.3M | $56.0M | ||
| Q3 24 | $143.8M | $17.7M | ||
| Q2 24 | $282.3M | $39.0M |
自由现金流率FMCLFST
| Q1 26 | -82.8% | — | ||
| Q4 25 | 58.3% | 12.2% | ||
| Q3 25 | -38.3% | 4.7% | ||
| Q2 25 | 4.8% | 16.4% | ||
| Q1 25 | -72.9% | -3.1% | ||
| Q4 24 | 33.2% | 17.2% | ||
| Q3 24 | 13.5% | 5.7% | ||
| Q2 24 | 27.2% | 12.5% |
资本支出强度FMCLFST
| Q1 26 | 2.2% | — | ||
| Q4 25 | 2.4% | 2.9% | ||
| Q3 25 | 4.4% | 2.8% | ||
| Q2 25 | 1.4% | 2.2% | ||
| Q1 25 | 4.0% | 2.2% | ||
| Q4 24 | 1.8% | 1.9% | ||
| Q3 24 | 1.5% | 1.6% | ||
| Q2 24 | 1.0% | 1.6% |
现金转化率FMCLFST
| Q1 26 | — | — | ||
| Q4 25 | — | 4.93× | ||
| Q3 25 | — | 25.34× | ||
| Q2 25 | 0.99× | — | ||
| Q1 25 | — | -4.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.45× | — | ||
| Q2 24 | 0.99× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FMC
| EMEA | $307.0M | 40% |
| North America | $198.0M | 26% |
| Latin America | $177.0M | 23% |
| Asia (excluding 2026 India) 1 | $81.0M | 11% |
LFST
暂无分部数据
